Jocelyn Spragg

766 total citations
26 papers, 589 citations indexed

About

Jocelyn Spragg is a scholar working on Genetics, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Jocelyn Spragg has authored 26 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Immunology. Recurrent topics in Jocelyn Spragg's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (20 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Complement system in diseases (3 papers). Jocelyn Spragg is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (20 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Complement system in diseases (3 papers). Jocelyn Spragg collaborates with scholars based in United States and Austria. Jocelyn Spragg's co-authors include K. Frank Austen, K. Frank Austen, Onesmo K. ole-MoiYoi, Edgar Haber, Geraldine S. Pinkus, Roger W. Yurt, Michael E. Weinblatt, Patricia A. Fraser, Jonathan S. Coblyn and Ronald J. Anderson and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Journal of Immunology.

In The Last Decade

Jocelyn Spragg

26 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jocelyn Spragg United States 14 258 214 120 103 75 26 589
Annette Eckardt United States 12 240 0.9× 230 1.1× 85 0.7× 440 4.3× 41 0.5× 20 861
Joseph T. Dunn United States 8 416 1.6× 154 0.7× 113 0.9× 250 2.4× 41 0.5× 9 741
J Kuchibhotla United States 7 81 0.3× 160 0.7× 73 0.6× 70 0.7× 19 0.3× 9 365
William H. Towns United States 12 218 0.8× 325 1.5× 146 1.2× 62 0.6× 28 0.4× 18 690
Sarah M. Jacobs-Helber United States 13 101 0.4× 391 1.8× 288 2.4× 193 1.9× 47 0.6× 16 782
Florence Namour Belgium 14 150 0.6× 188 0.9× 81 0.7× 99 1.0× 167 2.2× 29 646
Tetsuya Kurosu Japan 18 179 0.7× 473 2.2× 97 0.8× 327 3.2× 84 1.1× 35 831
Chris Planque France 15 181 0.7× 297 1.4× 121 1.0× 76 0.7× 43 0.6× 20 624
I. L. O. Ponting United Kingdom 9 51 0.2× 213 1.0× 177 1.5× 171 1.7× 18 0.2× 12 511
Adam J. Cotterell Australia 9 162 0.6× 190 0.9× 80 0.7× 305 3.0× 13 0.2× 10 506

Countries citing papers authored by Jocelyn Spragg

Since Specialization
Citations

This map shows the geographic impact of Jocelyn Spragg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jocelyn Spragg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jocelyn Spragg more than expected).

Fields of papers citing papers by Jocelyn Spragg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jocelyn Spragg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jocelyn Spragg. The network helps show where Jocelyn Spragg may publish in the future.

Co-authorship network of co-authors of Jocelyn Spragg

This figure shows the co-authorship network connecting the top 25 collaborators of Jocelyn Spragg. A scholar is included among the top collaborators of Jocelyn Spragg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jocelyn Spragg. Jocelyn Spragg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anbar, Ran D., Allen Lapey, Kon‐Taik Khaw, et al.. (1990). Does lithium carbonate affect the ion transport abnormality in cystic fibrosis?. Pediatric Pulmonology. 8(2). 82–88. 8 indexed citations
2.
Spragg, Jocelyn, Raymond J. Vavrek, & John M. Stewart. (1988). The inhibition of glandular kallikrein by peptide analog antagonists of bradykinin. Peptides. 9(1). 203–206. 10 indexed citations
3.
Spragg, Jocelyn. (1988). [9] Latent kallikrein from human urine. Methods in enzymology on CD-ROM/Methods in enzymology. 163. 96–102. 4 indexed citations
4.
Weinblatt, Michael E., Jonathan S. Coblyn, Patricia A. Fraser, et al.. (1987). Cyclosporin A Treatment of Refractory Rheumatoid Arthritis. Arthritis & Rheumatism. 30(1). 11–17. 110 indexed citations
5.
Spragg, Jocelyn, et al.. (1985). Kallikrein excretion in renal transplant recipients and in uninephrectomized donors. Kidney International. 28(1). 75–81. 9 indexed citations
6.
Maier, Manfred, K. Frank Austen, & Jocelyn Spragg. (1983). Purification of single-chain human low-molecular-weight kininogen and demonstration of its cleavage by human urinary kallikrein. Analytical Biochemistry. 134(2). 336–346. 17 indexed citations
7.
Levinsky, Norman G., Onesmo K. ole-MoiYoi, K. Frank Austen, & Jocelyn Spragg. (1979). Measurement of human urinary kallikrein and evidence for non-kallikrein urinary tame esterases by direct immunoassay and by affinity chromatography. Biochemical Pharmacology. 28(16). 2491–2495. 14 indexed citations
8.
ole-MoiYoi, Onesmo K., Geraldine S. Pinkus, Jocelyn Spragg, & K. Frank Austen. (1979). Identification of Human Glandular Kallikrein in the Beta Cell of the Pancreas. New England Journal of Medicine. 300(23). 1289–1294. 45 indexed citations
9.
ole-MoiYoi, Onesmo K., David C. Seldin, Jocelyn Spragg, Geraldine S. Pinkus, & K. Frank Austen. (1979). Sequential cleavage of proinsulin by human pancreatic kallikrein and a human pancreatic kininase. Proceedings of the National Academy of Sciences. 76(8). 3612–3616. 51 indexed citations
11.
ole-MoiYoi, Onesmo K., Jocelyn Spragg, & K. Frank Austen. (1978). Inhibition of Human Urinary Kallikrein (Urokallikrein) by Anti-Enzyme Fab. The Journal of Immunology. 121(1). 66–71. 14 indexed citations
12.
ole-MoiYoi, Onesmo K., Jocelyn Spragg, Seymour P. Halbert, & K. Frank Austen. (1977). Immunologic Reactivity of Purified Human Urinary Kallikrein (Urokallikrein) with Antiserum Directed against Human Pancreas. The Journal of Immunology. 118(2). 667–672. 9 indexed citations
13.
Spragg, Jocelyn, et al.. (1975). Interaction of hageman factor dependent systems with the complement sequence. Life Sciences. 16(5). 802–803. 3 indexed citations
14.
Austen, K. Frank, et al.. (1974). Immunoelectrophoretic analysis and radial immunodiffusion assay using plasminogen purified from fresh human plasma.. PubMed. 17(2). 345–59. 8 indexed citations
15.
Spragg, Jocelyn & K. Frank Austen. (1974). Preparation of human kininogen—III. Biochemical Pharmacology. 23(4). 781–791. 13 indexed citations
16.
Spragg, Jocelyn & K. Frank Austen. (1971). the preparation of human kininogen. II. Further characterization of purified human kininogen.. PubMed. 107(6). 1512–9. 29 indexed citations
17.
Spragg, Jocelyn & K. Frank Austen. (1971). The Preparation of Human Kininogen. The Journal of Immunology. 107(6). 1512–1519. 18 indexed citations
18.
Spragg, Jocelyn, Edgar Haber, & K. Frank Austen. (1970). The Preparation of Human Kininogen and the Elicitation of Antibody for Use in a Radial Immuno-Diffusion Assay. The Journal of Immunology. 104(6). 1348–1354. 15 indexed citations
19.
Spragg, Jocelyn, E. Schröder, John M. Stewart, K. Frank Austen, & Edgar Haber. (1967). Structural Requirements for Binding to Antibody of Sequence Variants of Bradykinin*. Biochemistry. 6(12). 3933–3941. 24 indexed citations
20.
Spragg, Jocelyn, K. Frank Austen, & Edgar Haber. (1966). Production of Antibody against Bradykinin: Demonstration of Specificity by Complement Fixation and Radio-Immunoassay. The Journal of Immunology. 96(5). 865–871. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026